由 John W. Mitchell
, Senior Correspondent | November 30, 2016
While a conceptual HoloLens 3-D Viewing application is attracting a lot of attention to the Novarad booth at RSNA this week in Chicago, its market-ready digital radiology solution, ChameleonDR, and its new Ncompass workflow offering are the company's innovations that will matter most to radiologists and hospital decision-makers.
“The ChameleonDR wireless solution offers 15 MB images on a 4K monitor in seconds,” Steve Fowler, director of product management with Novarad told HCB News. “We offer significantly sharper images with six proprietary algorithms to improve image quality.”
According to Fowler, these include such image adjustment options as invert, equalize histogram and contrast equalization, as well as auto rotation. He said that such innovations enable hospitals and clinics to lay ChameleonDR over their existing film component platforms.
Midwest Hand Surgery Auction Closing 5/26 at 8PM. Hologic Fluoroscan Insight-FD Mini C-Arm, Nuvo Dual-Lamp Surgical Lighting System W/Control Panel, Ritter M11 Ultraclave Automatic Sterilizer & More! 2 Day Women's Treatment Center Auction Coming Soon!
He also cited the lower dose the conversion to digital creates through much-improved image quality – in some instances up to a 300 percent lower dose. This is critical as hospitals scramble to meet new 2017 regulations
, under which inpatient imaging operations must convert to digital radiology to avoid reduced Medicare payments for film or computed radiology scans.
“What’s important right now is making this transition as painless as possible for all health care providers,” Fowler said.
The Ncompass enterprise imaging platform rollout is supported by the company’s same philosophy to bring all imaging data together with intuitive access, according to Fowler. The platform is designed to integrate with the existing electronic medical record and mobile viewing. It offers clinical workflow modules, such as radiology, cardiology, mammography and orthopedics.
He also stressed that they have not outsourced post-processing support to a third-party vendor.
“We know how to do that,” he noted. “We have that PACS expertise in-house, which we think is more secure and better care for our customer’s patients.”
No doubt the biggest interest generated at RSNA by Novarad was the demonstration of its HoloLens 3D viewing innovation. On Tuesday, RSNA visitors surrounded the display throughout the day. They were offered the opportunity to don a 3-D headset to manipulate a virtual medical image projected over a model patient's body.
Currently the augmented reality product is only for use in research and academic settings, but Fowler said the company’s goal is to eventually position the technology for everyday use by radiologists and surgeons.Back to HCB News